« Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement a »

Reply to Valproic Acid for the Treatment of Myeloid Malignancies.

Reply to Valproic Acid for the Treatment of Myeloid Malignancies.

Kuendgen A, Gattermann N, Krieger O.

Department of Hematology, Oncology, and Clinical Immunology, Heinrich Heine University, Dusseldorf, Germany.

This entry was posted on Wednesday, March 19th, 2008 at 5:57 pm and is filed under c3. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

,